Related Experiment Videos
Summary
Monoclonal antibody D51 binds leukemic cells, identifying the transferrin receptor. This antibody immunoprecipitates a dimeric protein, confirming its role in transferrin receptor recognition.
Area of Science:
- Immunology
- Cell Biology
- Hematology
Background:
- Monoclonal antibodies are crucial tools in cell surface antigen research.
- The transferrin receptor is implicated in cell proliferation and is a target in various diseases.
Purpose of the Study:
- To characterize a newly developed monoclonal antibody, D51, generated against human fetal thymus.
- To determine the binding specificity and molecular target of D51.
Main Methods:
- Immunization of mice against human fetal thymus to generate monoclonal antibodies.
- Flow cytometry to assess antibody binding to leukemic cell lines.
- Immunoprecipitation assays under reducing and non-reducing conditions to identify the target protein.
- Cross-competition assays using known transferrin receptor antibodies (OKT9).
Main Results:
- Monoclonal antibody D51 binds to a range of leukemic cells.
- D51 immunoprecipitates a protein with a molecular weight of 90 kDa under reducing conditions and 180 kDa under non-reducing conditions, suggesting a dimeric structure.
- Consecutive immunoprecipitation experiments confirm that D51 recognizes the transferrin receptor, similar to mAb OKT9.
Conclusions:
- Monoclonal antibody D51 is a valuable reagent for identifying the transferrin receptor on leukemic cells.
- The findings support the dimeric structure of the transferrin receptor.
- D51 provides an additional tool for studying transferrin receptor expression in hematological malignancies.